Weaver, James http://orcid.org/0000-0003-0755-5191
Shoaibi, Azza http://orcid.org/0000-0002-6976-2594
Truong, Huy Q.
Larbi, Leila
Wu, Shujian
Wildgoose, Peter
Rao, Gowtham
Freedman, Amy
Wang, Lu http://orcid.org/0000-0001-7225-9407
Yuan, Zhong http://orcid.org/0000-0002-5824-2040
Barnathan, Elliot
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA
https://doi.org/10.1007/s40264-021-01060-4
Funding for this research was provided by:
Janssen Research and Development
Article History
Accepted: 16 February 2021
First Online: 2 March 2021
Declarations
:
: This study was funded by Janssen Research & Development, LLC.
: All authors are full-time employees of Janssen Research & Development, LLC and may be stockholders of Johnson & Johnson.
: Analyses of de-identified, publicly available data do not constitute human subjects research and, as such, do not require institutional review board review/approval.
: Not applicable.
: Not applicable.
: The full result set with associated study diagnostics is publicly available in an interactive web application at ExternalRef removed.
: The code is available at ExternalRef removed.
: JW, AS, HQT, LL, SW, PW, GR, AF, LW, ZY, and EB contributed to the conception of the study, the design, interpretation of the results, writing and editing of the manuscript, and final approval of the manuscript. JW and AS conducted the data analysis.